| 20.03 Real-Time Quote | +0.43 / +2.19%Today’s Change | 10.85 Today|||52-Week Range 20.51 | +66.36% Year-to-Date |
| Actavis: The latest Fortune 500 company to "leave" the U.S. for tax reasons 11:23am / Fortune | Actavis to acquire Warner Chilcott in $5bn pharmaceutical deal May 20 / FT.com |
| Ireland Welcomes Watson Pharmaceuticals, an American Success May 20 / TheStreet.com | Yahoo in focus as stocks stick near record highs May 20 / CNNMoney.com |
| Actavis/Warner Chilcott: simple medicine May 20 / FT.com | Earnings Beat at Warner Chilcott - Analyst Blog May 13 / Zacks.com |
| The biggest merger you didn't hear about today May 20 / Fortune | Actavis in talks to buy Warner Chilcott May 10 / FT.com |
| Warner Chilcott Rises On Unusually High Volume (WCRX) May 20 / TheStreet.com | Warner Chilcott Beats Expectations But Takes A Step Back Anyway May 10 / MotleyFool.com |
| The Deal: Actavis Plays Hunter in $8.5 Billion Deal for Ireland's Warner Chilcott May 20 / TheStreet.com | Great tax race: Netherlands' complex web of tax loopholes and treaties Apr 29 / FT.com |